Skip to content

Evaluation of the effect of quaternary HPV vaccine in the treatment of women with cervical intraepithelial neoplasia cin1

Evaluation of the effect of quaternary HPV vaccine in the treatment of women with cervical intraepithelial neoplasia cin1

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230522058253N2
Enrollment
300
Registered
2023-10-26
Start date
2022-07-23
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of the effect of quaternary HPV vaccine in the treatment of women with cervical intraepithelial neoplasia cin1 of Fatemiye Hospitan, Hamadan.

Interventions

Intervention 1: Intervention group: Women in the intervention group will receive conservative treatment according to the ASCCP algorithm along with quadrivalent HPV vaccination (Gardasil). Gardasil ta

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age 21 to 45 years not currently pregnant not having had more than one sexual partner during their period received conservative treatment. women with histologically confirmed CIN 1

Exclusion criteria

Exclusion criteria: women who became pregnant received only one dose of the vaccine, or allergic to the vaccine Those who have been cin 1 for more than 24 month Those who do not participate in the study (non-cooperation) will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Histological biopsy status of CIN 1 lesions in two control and intervention groups. Timepoint: To measure this criterion, women are visited three times (months 12, 18,24) and undergo gynecological examination and pap smear test, colposcopy and annual biopsy and in 18 undergo gynecological examination and pap smear test (in case of pap smear test suspicious) have been placed. Method of measurement: To measure this criterion, women are visited three times (months 12, 18, 24) and undergo gynecological examination and pap smear test, colposcopy and annual biopsy and in 18 undergo gynecological examination and pap smear test (in case of pap smear test suspicious) have been placed.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrangiz Zamani bonab

Hamedan University of Medical Sciences

mehrangiz.zamani@umsha.ac.ir+98 81 3827 7013

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026